reiterateUPBDfinnhub
TD Cowen Reiterates Buy Rating on Upbound Group, Inc. (UPBD)
Rating Change TD Cowen analysts reiterated a Buy rating on Upbound Group, Inc. (NASDAQ:UPBD) on July 07, 2026. Market Context Upbound Group, Inc.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Rating Change TD Cowen analysts reiterated a Buy rating on Upbound Group, Inc. (NASDAQ:UPBD) on July 07, 2026. Market Context Upbound Group, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on 7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (NYSE:RZC) on July 07, 2026. Market Context 7.125%…
Read moreRating Change Susquehanna analysts reiterated a Neutral rating on JetBlue Airways Corporation (NASDAQ:JBLU) on July 07, 2026. Market Context JetBlue Airways Corporation operates…
Read moreRating Change Truist Securities analysts reiterated a Buy rating on Nuvation Bio Inc. (NYSE:NUVB) on July 07, 2026. Market Context Nuvation Bio Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Nuvation Bio Inc. (NYSE:NUVB) on July 07, 2026. Market Context Nuvation Bio Inc.
Read moreRating Change Morgan Stanley analysts initiated coverage on Kingsoft Cloud Holdings Limited (NASDAQ:KC) with a Overweight rating on July 07, 2026. Market Context Kingsoft Cloud…
Read moreRating Change B of A Securities analysts reiterated a Buy rating on Vera Therapeutics, Inc. (NASDAQ:VERA) on July 07, 2026. Market Context Vera Therapeutics, Inc.
Read moreRating Change Truist Securities analysts reiterated a Buy rating on IDEAYA Biosciences, Inc. (NASDAQ:IDYA) on July 07, 2026. Market Context IDEAYA Biosciences, Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on IDEAYA Biosciences, Inc. (NASDAQ:IDYA) on July 07, 2026. Market Context IDEAYA Biosciences, Inc.
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on Telix Pharmaceuticals Limited (NASDAQ:TLX) on July 07, 2026. Market Context Telix Pharmaceuticals Limited…
Read moreRating Change Citigroup analysts reiterated a Buy rating on Telix Pharmaceuticals Limited (NASDAQ:TLX) on July 07, 2026. Market Context Telix Pharmaceuticals Limited operates in…
Read moreRating Change Goldman Sachs analysts reiterated a Sell rating on First Hawaiian, Inc. (NASDAQ:FHB) on July 07, 2026. Market Context First Hawaiian, Inc.
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on First Hawaiian, Inc. (NASDAQ:FHB) on July 07, 2026. Market Context First Hawaiian, Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) on July 07, 2026. Market Context Mirum Pharmaceuticals, Inc.
Read moreRating Change Deutsche Bank analysts reiterated a Buy rating on Dana Incorporated (NYSE:DAN) on July 07, 2026. Market Context Dana Incorporated operates in the Consumer Cyclical…
Read moreRating Change B of A Securities analysts reiterated a Buy rating on Northern Trust Corporation (NASDAQ:NTRSO) on July 07, 2026. Market Context Northern Trust Corporation operates…
Read moreRating Change Evercore ISI Group analysts reiterated a In-Line rating on Tanger Inc. (NYSE:SKT) on July 07, 2026. Market Context Tanger Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Voya Financial, Inc. (NYSE:VOYA) on July 07, 2026. Market Context Voya Financial, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Jackson Financial Inc. (NYSE:JXN) on July 07, 2026. Market Context Jackson Financial Inc.
Read moreRating Change TD Cowen analysts reiterated a Buy rating on FirstCash Holdings, Inc (NASDAQ:FCFS) on July 07, 2026. Market Context FirstCash Holdings, Inc operates in the Financial…
Read more